704. Pilot program on opioid management in the military health system (a) Pilot program (1) In general Beginning not later than 180 days after the date of the enactment of this Act, the Director of the Defense Health Agency shall implement a comprehensive pilot program to minimize early opioid exposure in beneficiaries under the TRICARE program and to prevent progression to misuse or abuse of opioid medications. (2) Opioid safety across continuum of care The pilot program shall include elements to maximize opioid safety across the entire continuum of care consisting of patient, physician or dentist, and pharmacist. (b) Elements of pilot program The pilot program shall include the following: (1) Identification of potential opioid misuse or abuse in pharmacies of military treatment facilities, retail network pharmacies, and the home delivery pharmacy and transmission of alerts regarding such potential mistreatment to opioid prescribing physicians or dentists. (2) Direct engagement with, education for, and management of beneficiaries under the TRICARE program to help such beneficiaries avoid opioid misuse or abuse. (3) Provision of in-home disposal kits to deactivate excess opioids and prevent unauthorized use. (4) Proactive outreach by specialist pharmacists to such beneficiaries when identifying potential opioid misuse or abuse. (5) Monitoring of such beneficiaries through the use of predictive analytics to identify the potential for abuse and addiction before such beneficiaries begin an opioid prescription. (6) Detection of fraud, waste, and abuse. (c) Report on pilot program (1) In general Not later than 180 days before completion of the pilot program, the Secretary of Defense shall submit to the Committees on Armed Services of the Senate and the House of Representatives a report that describes the conduct of the pilot program. (2) Elements The report required by paragraph (1) shall include the following: (A) A description of the pilot program, including outcome measures developed to determine the overall